Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Thomas Delvin

4PUBLICATIONS
5CO-AUTHORS
Molecular medicineDisease surveillanceEpidemiological modellingToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Dec 05, 2025
Unsuspected Adverse Drug Reactions to Dermatologic Medications: An Epidemiological Hypothesis-Free Screening Study of Real-World Data in Denmark.

Thomas Delvin, Anette Bygum, Lars Christian Lund

|Mar 12, 2024
Screening of dermatology drugs for aberrant use-patterns: An application of epidemiologic estimates and measures of inequality in drug use.

Thomas Delvin, Anette Bygum, Lars Christian Lund

|Mar 07, 2024
Is the sequence ratio an unbiased estimate of the incidence rate ratio? A simulation study.

Thomas Delvin, Sofie Egsgaard, Jesper Hallas

|Oct 27, 2023
Application of the waiting time distribution in a nationwide screening of real-world dermatology drug utilization for aberrant use patterns.

Thomas Delvin, Anette Bygum, Lars Christian Lund

Pageof 1

Frequent Collaborators

2 joint publications

Lars Christian Lund

2 joint publications

Jesper Hallas

1 joint publications

Sofie Egsgaard

1 joint publications

Helene Kildegaard

1 joint publications

Martin Torp Rahbek

Frequent Collaborators

2 joint publications

Lars Christian Lund

2 joint publications

Jesper Hallas

1 joint publications

Sofie Egsgaard

1 joint publications

Helene Kildegaard

Top Related Videos

Precision Implementation of Minimal Erythema Dose (MED) Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose (MED) Testing to Assess Individual Variation in Human Inflammatory Response

Published on : Oct 03, 2019

9.1K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on : Dec 11, 2016

9.6K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on : Sep 16, 2022

2.1K
See more related videos

Top Related Videos

Precision Implementation of Minimal Erythema Dose (MED) Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose (MED) Testing to Assess Individual Variation in Human Inflammatory Response

Published on : Oct 03, 2019

9.1K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on : Dec 11, 2016

9.6K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on : Sep 16, 2022

2.1K
See more related videos